carmustine has been researched along with Neutropenia in 41 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bacteremia was documented in two patients in the O+R group and six in the control group (p=0." | 5.30 | Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. ( Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A, 1999) |
| "Autologous stem cell transplantation after high-dose melphalan for the treatment with multiple myeloma has resulted in prolonged progression-free survival and overall survival in patients under 65 years." | 5.09 | The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. ( Bhagwati, N; Horton, C; Kulkarni, S; Mainwaring, P; Mehta, J; Pandha, H; Powles, R; Singhal, S; Sirohi, B; Treleaven, J, 2000) |
| " The distribution of adverse prognostic factors was comparable in the two-induction arm." | 2.70 | Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. ( Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A, 2001) |
| "Twenty-three patients were treated in first relapse and 10 in second or subsequent relapse; 21 received mini-BEAM as their first salvage regimen." | 2.68 | Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. ( Brandwein, JM; Colwill, R; Couture, F; Crump, M; Danish, R; Keating, A; Scott, JG; Stewart, AK; Sutcliffe, SB; Sutton, DM, 1995) |
| "Fifty-eight patients with previously untreated multiple myeloma were entered." | 2.68 | Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma. ( Gregory, SA; Greipp, PR; Kay, NE; Kyle, RA; O'Connell M, J; Oken, MM; Spiegel R, J; Tsiatis, A, 1996) |
| "Thirty-one patients with resistant Hodgkin's disease were treated by an identical high dose chemotherapy regimen and autologous bone marrow transplantation." | 2.66 | GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease. ( Devereaux, S; Goldstone, AH; Gribben, JG; Linch, DC; McMillan, A; Patterson, K, 1989) |
| "The treatment of Hodgkin's disease after relapse from chemotherapy or when resistant to chemotherapy rarely results in cure." | 2.38 | What is the value of autologous bone marrow transplantation in the treatment of relapsed or resistant Hodgkin's disease? ( Goldstone, A; McMillan, A, 1991) |
| "Fourteen (26%) patients with Hodgkin's lymphoma and 40 (74%) patients with non-Hodgkin's lymphoma were analyzed." | 1.36 | Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation. ( Buset, EM; Haile, SR; Honegger, H; Knuth, A; Mischo, A; Pestalozzi, BC; Petrausch, U; Renner, C; Samaras, P; Schanz, U; Siciliano, RD; Stahel, RA; Stenner-Liewen, F; Stussi, G, 2010) |
| "Mini-BEAM/HSC is an effective treatment for lymphoma relapses after allogeneic HSCT, but optimal strategies of remission consolidation and prevention of treatment-related complications are needed to improve outcome." | 1.32 | Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor. ( Au, WY; Chan, EC; Kwong, YL; Leung, AY; Liang, R; Lie, AK; Ooi, GC; Siu, LL, 2003) |
| "We studied 19 breast cancer (BC) patients and 17 multiple myeloma (MM) patients entered in a high-dose chemotherapy (HDC) program of tandem autografting with CD34+ cell-selected PBPC." | 1.32 | Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation. ( Amodeo, R; Anghel, G; De Rosa, L; Majolino, I; Pandolfi, A; Riccardi, M, 2004) |
| " The results of this study demonstrate that the use of CD34(+) cells is safe and has no adverse effects either with respect to haematological, immune reconstitution or to infections after HDT." | 1.31 | High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells. ( Blystad, AK; Delabie, J; Holte, H; Kvalheim, G; Kvaløy, S; Smeland, E, 2001) |
| "Bacteremia was documented in two patients in the O+R group and six in the control group (p=0." | 1.30 | Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. ( Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A, 1999) |
| "We present a patient with metastatic breast cancer treated with high-dose chemotherapy and bone marrow transplantation." | 1.29 | Clostridium septicum abscess in hepatic metastases: successful medical management. ( Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ, 1994) |
| "Thirty patients with relapsed Hodgkin's disease were treated with high-dose cyclophosphamide, carmustine, and etoposide (CBV) and autologous bone marrow transplantation." | 1.27 | High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. ( Armitage, JO; Cabanillas, FF; Dicke, KA; Horwitz, LJ; Jagannath, S; Spitzer, G; Vellekoop, L; Zander, AR, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (17.07) | 18.7374 |
| 1990's | 17 (41.46) | 18.2507 |
| 2000's | 12 (29.27) | 29.6817 |
| 2010's | 4 (9.76) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Heng, MS | 1 |
| Barbon Gauro, J | 1 |
| Yaxley, A | 1 |
| Thomas, J | 1 |
| Herbers, AH | 1 |
| van der Velden, WJ | 1 |
| de Haan, AF | 1 |
| Donnelly, JP | 1 |
| Blijlevens, NM | 1 |
| Cioch, M | 1 |
| Jawniak, D | 1 |
| Kotwica, K | 1 |
| Wach, M | 1 |
| Mańko, J | 1 |
| Gorący, A | 1 |
| Klimek, P | 1 |
| Mazurkiewicz, E | 1 |
| Jarosz, P | 1 |
| Hus, M | 1 |
| Gil, L | 1 |
| Kozlowska-Skrzypczak, M | 1 |
| Mol, A | 1 |
| Poplawski, D | 1 |
| Styczynski, J | 1 |
| Komarnicki, M | 1 |
| Rifkin, R | 1 |
| Spitzer, G | 4 |
| Orloff, G | 1 |
| Mandanas, R | 1 |
| McGaughey, D | 1 |
| Zhan, F | 1 |
| Boehm, KA | 1 |
| Asmar, L | 1 |
| Beveridge, R | 1 |
| Samaras, P | 1 |
| Buset, EM | 1 |
| Siciliano, RD | 1 |
| Haile, SR | 1 |
| Petrausch, U | 1 |
| Mischo, A | 1 |
| Honegger, H | 3 |
| Pestalozzi, BC | 1 |
| Schanz, U | 1 |
| Stussi, G | 1 |
| Stahel, RA | 3 |
| Knuth, A | 1 |
| Renner, C | 1 |
| Stenner-Liewen, F | 1 |
| Arellano-Rodrigo, E | 1 |
| López-Guillermo, A | 1 |
| Bessell, EM | 1 |
| Nomdedeu, B | 1 |
| Montserrat, E | 1 |
| Graus, F | 1 |
| Gottfredsson, M | 1 |
| Vredenburgh, JJ | 2 |
| Xu, J | 1 |
| Schell, WA | 1 |
| Perfect, JR | 1 |
| Au, WY | 1 |
| Lie, AK | 1 |
| Siu, LL | 1 |
| Chan, EC | 1 |
| Ooi, GC | 1 |
| Leung, AY | 1 |
| Liang, R | 1 |
| Kwong, YL | 1 |
| De Rosa, L | 1 |
| Anghel, G | 1 |
| Pandolfi, A | 1 |
| Riccardi, M | 1 |
| Amodeo, R | 1 |
| Majolino, I | 1 |
| Leger, C | 1 |
| Sabloff, M | 1 |
| McDiarmid, S | 1 |
| Bence-Bruckler, I | 1 |
| Atkins, H | 1 |
| Bredeson, C | 1 |
| Zhang, H | 1 |
| Huebsch, L | 1 |
| Christopeit, M | 1 |
| Haak, U | 1 |
| Behre, G | 1 |
| Volkin, RL | 1 |
| Shadduck, RK | 1 |
| Winkelstein, A | 1 |
| Zeigler, ZR | 1 |
| Selker, RG | 1 |
| Thel, MC | 1 |
| Ciaccia, D | 1 |
| Peters, W | 1 |
| Corey, GR | 1 |
| Jost, LM | 2 |
| Cerny, T | 1 |
| Pichert, G | 1 |
| Tobler, A | 1 |
| Jacky, E | 1 |
| Fey, M | 1 |
| Platzer, E | 1 |
| Dranitsaris, G | 1 |
| Sutcliffe, SB | 2 |
| Khwaja, A | 1 |
| Goldstone, AH | 2 |
| Linch, DC | 2 |
| Colwill, R | 1 |
| Crump, M | 1 |
| Couture, F | 1 |
| Danish, R | 1 |
| Stewart, AK | 1 |
| Sutton, DM | 1 |
| Scott, JG | 1 |
| Brandwein, JM | 1 |
| Keating, A | 1 |
| Mitchell, RB | 1 |
| Dolan, ME | 1 |
| Janisch, L | 1 |
| Vogelzang, NJ | 1 |
| Ratain, MJ | 1 |
| Schilsky, RL | 1 |
| Rampling, R | 1 |
| Steward, W | 1 |
| Paul, J | 1 |
| Macham, MA | 1 |
| Harvey, E | 1 |
| Eckley, D | 1 |
| Oken, MM | 1 |
| Kyle, RA | 1 |
| Greipp, PR | 1 |
| Kay, NE | 1 |
| Tsiatis, A | 1 |
| Gregory, SA | 1 |
| Spiegel R, J | 1 |
| O'Connell M, J | 1 |
| Merouani, A | 1 |
| Shpall, EJ | 1 |
| Jones, RB | 1 |
| Archer, PG | 1 |
| Schrier, RW | 1 |
| Caballero, MD | 1 |
| Amigo, ML | 1 |
| Hernández, JM | 1 |
| Vazquez, L | 1 |
| del Cañizo, C | 1 |
| Gonzalez, M | 1 |
| García, R | 1 |
| San Miguel, JF | 1 |
| Betts, E | 1 |
| Goebel, ME | 1 |
| Nagler, A | 1 |
| Salloum, E | 2 |
| Jillella, AP | 2 |
| Nadkarni, R | 2 |
| Seropian, S | 2 |
| Hu, GL | 2 |
| D'Andrea, E | 1 |
| Zelterman, D | 2 |
| Cooper, DL | 2 |
| Burtness, B | 1 |
| Muñoz, L | 1 |
| Martino, R | 1 |
| Subirà, M | 1 |
| Brunet, S | 1 |
| Sureda, A | 1 |
| Sierra, J | 1 |
| Kozák, T | 1 |
| Havrdová, E | 1 |
| Pit'ha, J | 1 |
| Gregora, E | 1 |
| Pytlík, R | 1 |
| Maaloufová, J | 1 |
| Marecková, H | 1 |
| Kobylka, P | 1 |
| Vodvárková, S | 1 |
| Sirohi, B | 1 |
| Powles, R | 1 |
| Treleaven, J | 1 |
| Mainwaring, P | 1 |
| Kulkarni, S | 1 |
| Pandha, H | 1 |
| Bhagwati, N | 1 |
| Horton, C | 1 |
| Singhal, S | 1 |
| Mehta, J | 1 |
| Weiss, M | 1 |
| Hunault-Berger, M | 1 |
| Milpied, N | 2 |
| Bernard, M | 1 |
| Jouet, JP | 1 |
| Delain, M | 1 |
| Desablens, B | 2 |
| Sadoun, A | 1 |
| Guilhot, F | 1 |
| Casassus, P | 2 |
| Ifrah, N | 2 |
| Blystad, AK | 1 |
| Holte, H | 1 |
| Kvaløy, S | 1 |
| Smeland, E | 1 |
| Delabie, J | 1 |
| Kvalheim, G | 1 |
| Dicke, KA | 2 |
| Verma, DS | 1 |
| Zander, A | 1 |
| McCredie, KB | 1 |
| Udupa, KB | 2 |
| Reissmann, KR | 2 |
| Deisseroth, A | 1 |
| Ventura, G | 1 |
| Jagannath, S | 2 |
| Fogel, B | 1 |
| Taylor, K | 1 |
| Huan, S | 1 |
| Dunphy, F | 1 |
| Dicke, K | 1 |
| Souza, L | 1 |
| McMillan, A | 2 |
| Goldstone, A | 1 |
| Harousseau, JL | 1 |
| Briere, J | 1 |
| Le Prise, PY | 1 |
| Gandhour, C | 1 |
| Devereaux, S | 1 |
| Gribben, JG | 1 |
| Patterson, K | 1 |
| Armitage, JO | 1 |
| Cabanillas, FF | 1 |
| Horwitz, LJ | 1 |
| Vellekoop, L | 1 |
| Zander, AR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Efficacy and Safety of IBER Salvage Treatment Followed by Ibrutinib Maintenance for Transplant-ineligible Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL): a Multicenter, Single-arm, Prospective Phase II Study[NCT04066920] | Phase 2 | 30 participants (Anticipated) | Interventional | 2019-10-01 | Not yet recruiting | ||
| Prevention Of Nephrotoxicity Following Allogeneic Bone Marrow Transplantation Using Urodilatin (Ularitide,Atrial Natriuretic Peptide) and Mannitol.[NCT00390624] | Phase 2 | 20 participants (Anticipated) | Interventional | 2003-07-31 | Completed | ||
| Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma[NCT00001270] | Phase 1 | 85 participants | Interventional | 1991-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for carmustine and Neutropenia
| Article | Year |
|---|---|
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials | 2001 |
What is the value of autologous bone marrow transplantation in the treatment of relapsed or resistant Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carmustine | 1991 |
14 trials available for carmustine and Neutropenia
| Article | Year |
|---|---|
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabin | 2010 |
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosp | 2006 |
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1994 |
Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Fever; Granulocyt | 1995 |
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1995 |
Sequential therapy with dacarbazine and carmustine: a phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Dacarbazine; Drug Administr | 1994 |
rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.
Topics: Adult; Brain Neoplasms; Carmustine; Female; Glioblastoma; Glioma; Granulocyte-Macrophage Colony-Stim | 1994 |
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cycloph | 1996 |
Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; | 1996 |
Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1997 |
High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.
Topics: Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carmustine; CD4-CD8 | 2000 |
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Chem | 2000 |
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 2001 |
GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmus | 1989 |
25 other studies available for carmustine and Neutropenia
| Article | Year |
|---|---|
Does a neutropenic diet reduce adverse outcomes in patients undergoing chemotherapy?
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial I | 2020 |
Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C-Reactive Prot | 2014 |
Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.
Topics: Adult; Biosimilar Pharmaceuticals; Carmustine; Female; Filgrastim; Granulocyte Colony-Stimulating Fa | 2014 |
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2009 |
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Administra | 2010 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine | 2003 |
Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantatio | 2003 |
Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Gr | 2003 |
Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasm | 2004 |
Late-onset neutropenia following viral bone marrow depression after rituximab therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2008 |
Potentiation of carmustine-cranial irradiation-induced myelosuppression by cimetidine.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Cimetidine; Drug Synergism; Female; Glioma; Guanidines; He | 1982 |
Alternative mechanisms for severe neutropenia.
Topics: Agranulocytosis; Carmustine; Cimetidine; Drug Interactions; Humans; Neutropenia | 1982 |
Clostridium septicum abscess in hepatic metastases: successful medical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1994 |
Delayed neutrophil recovery after BEAM chemotherapy and autologous bone marrow transplantation for lymphoma is not associated with increased mortality from infection.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation | 1995 |
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Etop | 1997 |
Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; | 1998 |
Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.
Topics: Adult; Ambulatory Care; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carm | 1999 |
Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bact | 1999 |
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combi | 2001 |
High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations.
Topics: Adult; Aged; Bone Marrow Transplantation; Carcinoma; Carmustine; Female; Freezing; Humans; Male; Mel | 1979 |
Stimulation of granulopoiesis by androgens without concomitant increase in the serum level of colony stimulating factor.
Topics: Agranulocytosis; Animals; Bone Marrow; Bone Marrow Cells; Carmustine; Cell Division; Colony-Stimulat | 1975 |
Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Specimen Co | 1990 |
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmu | 1990 |
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1986 |
Acceleration of granulopoietic recovery by androgenic steroids in mice made neutropenic by cytotoxic drugs.
Topics: Agranulocytosis; Androgens; Animals; Bone Marrow; Busulfan; Carmustine; Cell Division; Clone Cells; | 1974 |